nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—CYP2D6—schizophrenia	0.559	1	CbGaD
Quinidine barbiturate—KCNK1—forebrain—schizophrenia	0.00498	0.0477	CbGeAlD
Quinidine barbiturate—KCNK1—telencephalon—schizophrenia	0.00458	0.0439	CbGeAlD
Quinidine barbiturate—GRIA2—forebrain—schizophrenia	0.00405	0.0388	CbGeAlD
Quinidine barbiturate—CYP2D6—urine—schizophrenia	0.0039	0.0374	CbGeAlD
Quinidine barbiturate—GRIA2—telencephalon—schizophrenia	0.00373	0.0357	CbGeAlD
Quinidine barbiturate—KCNK1—midbrain—schizophrenia	0.00329	0.0315	CbGeAlD
Quinidine barbiturate—KCNK1—nervous system—schizophrenia	0.0027	0.0259	CbGeAlD
Quinidine barbiturate—GRIA2—midbrain—schizophrenia	0.00268	0.0256	CbGeAlD
Quinidine barbiturate—GABRA2—forebrain—schizophrenia	0.00263	0.0252	CbGeAlD
Quinidine barbiturate—KCNK1—central nervous system—schizophrenia	0.0026	0.0249	CbGeAlD
Quinidine barbiturate—GABRA1—forebrain—schizophrenia	0.00255	0.0244	CbGeAlD
Quinidine barbiturate—KCNK1—cerebellum—schizophrenia	0.00254	0.0244	CbGeAlD
Quinidine barbiturate—CHRM2—forebrain—schizophrenia	0.00253	0.0243	CbGeAlD
Quinidine barbiturate—GABRA2—telencephalon—schizophrenia	0.00242	0.0232	CbGeAlD
Quinidine barbiturate—GRIA2—endocrine gland—schizophrenia	0.00235	0.0225	CbGeAlD
Quinidine barbiturate—GABRA1—telencephalon—schizophrenia	0.00234	0.0224	CbGeAlD
Quinidine barbiturate—CHRM2—telencephalon—schizophrenia	0.00233	0.0223	CbGeAlD
Quinidine barbiturate—Phenobarbital—CHRFAM7A—schizophrenia	0.0023	0.191	CrCbGaD
Quinidine barbiturate—GRIA2—nervous system—schizophrenia	0.0022	0.0211	CbGeAlD
Quinidine barbiturate—GRIA2—central nervous system—schizophrenia	0.00212	0.0203	CbGeAlD
Quinidine barbiturate—GRIA2—cerebellum—schizophrenia	0.00207	0.0198	CbGeAlD
Quinidine barbiturate—KCNK1—brain—schizophrenia	0.00207	0.0198	CbGeAlD
Quinidine barbiturate—CYP2D6—blood plasma—schizophrenia	0.00204	0.0195	CbGeAlD
Quinidine barbiturate—SCN5A—blood—schizophrenia	0.00199	0.0191	CbGeAlD
Quinidine barbiturate—KCNH2—forebrain—schizophrenia	0.00183	0.0175	CbGeAlD
Quinidine barbiturate—GRIA2—brain—schizophrenia	0.00168	0.0161	CbGeAlD
Quinidine barbiturate—KCNH2—telencephalon—schizophrenia	0.00168	0.0161	CbGeAlD
Quinidine barbiturate—GABRA1—midbrain—schizophrenia	0.00168	0.0161	CbGeAlD
Quinidine barbiturate—SCN5A—nervous system—schizophrenia	0.00162	0.0155	CbGeAlD
Quinidine barbiturate—SCN5A—central nervous system—schizophrenia	0.00155	0.0149	CbGeAlD
Quinidine barbiturate—CHRM2—endocrine gland—schizophrenia	0.00147	0.0141	CbGeAlD
Quinidine barbiturate—GABRA2—nervous system—schizophrenia	0.00143	0.0137	CbGeAlD
Quinidine barbiturate—GABRA1—nervous system—schizophrenia	0.00138	0.0132	CbGeAlD
Quinidine barbiturate—GABRA2—central nervous system—schizophrenia	0.00138	0.0132	CbGeAlD
Quinidine barbiturate—CHRM2—nervous system—schizophrenia	0.00137	0.0132	CbGeAlD
Quinidine barbiturate—GABRA2—cerebellum—schizophrenia	0.00135	0.0129	CbGeAlD
Quinidine barbiturate—GABRA1—central nervous system—schizophrenia	0.00133	0.0127	CbGeAlD
Quinidine barbiturate—CHRM2—central nervous system—schizophrenia	0.00132	0.0127	CbGeAlD
Quinidine barbiturate—Phenobarbital—CHRNA7—schizophrenia	0.00132	0.11	CrCbGaD
Quinidine barbiturate—GABRA1—cerebellum—schizophrenia	0.0013	0.0125	CbGeAlD
Quinidine barbiturate—Phenobarbital—GRIK2—schizophrenia	0.00124	0.103	CrCbGaD
Quinidine barbiturate—SCN5A—brain—schizophrenia	0.00123	0.0118	CbGeAlD
Quinidine barbiturate—Quinine—CYP1A2—schizophrenia	0.00123	0.102	CrCbGaD
Quinidine barbiturate—KCNH2—blood—schizophrenia	0.00122	0.0117	CbGeAlD
Quinidine barbiturate—KCNH2—midbrain—schizophrenia	0.00121	0.0116	CbGeAlD
Quinidine barbiturate—CYP2D6—forebrain—schizophrenia	0.00112	0.0107	CbGeAlD
Quinidine barbiturate—GABRA2—brain—schizophrenia	0.00109	0.0105	CbGeAlD
Quinidine barbiturate—Quinidine—CYP1A2—schizophrenia	0.00108	0.0895	CrCbGaD
Quinidine barbiturate—KCNH2—endocrine gland—schizophrenia	0.00106	0.0102	CbGeAlD
Quinidine barbiturate—Phenobarbital—CHRNA4—schizophrenia	0.00106	0.0879	CrCbGaD
Quinidine barbiturate—GABRA1—brain—schizophrenia	0.00106	0.0101	CbGeAlD
Quinidine barbiturate—CHRM2—brain—schizophrenia	0.00105	0.0101	CbGeAlD
Quinidine barbiturate—CYP2D6—telencephalon—schizophrenia	0.00103	0.00982	CbGeAlD
Quinidine barbiturate—KCNH2—nervous system—schizophrenia	0.000993	0.00951	CbGeAlD
Quinidine barbiturate—KCNH2—central nervous system—schizophrenia	0.000956	0.00916	CbGeAlD
Quinidine barbiturate—Quinine—CYP2D6—schizophrenia	0.000946	0.0786	CrCbGaD
Quinidine barbiturate—KCNH2—cerebellum—schizophrenia	0.000935	0.00895	CbGeAlD
Quinidine barbiturate—Quinidine—CYP2D6—schizophrenia	0.000831	0.0691	CrCbGaD
Quinidine barbiturate—KCNH2—brain—schizophrenia	0.000759	0.00727	CbGeAlD
Quinidine barbiturate—CYP2D6—blood—schizophrenia	0.000746	0.00714	CbGeAlD
Quinidine barbiturate—Quinine—ABCB1—schizophrenia	0.000676	0.0561	CrCbGaD
Quinidine barbiturate—CYP2D6—endocrine gland—schizophrenia	0.000647	0.0062	CbGeAlD
Quinidine barbiturate—CYP2D6—nervous system—schizophrenia	0.000606	0.0058	CbGeAlD
Quinidine barbiturate—Quinidine—ABCB1—schizophrenia	0.000594	0.0493	CrCbGaD
Quinidine barbiturate—CYP2D6—central nervous system—schizophrenia	0.000583	0.00558	CbGeAlD
Quinidine barbiturate—CYP2D6—cerebellum—schizophrenia	0.00057	0.00546	CbGeAlD
Quinidine barbiturate—Phenobarbital—CYP1A2—schizophrenia	0.000488	0.0406	CrCbGaD
Quinidine barbiturate—CYP2D6—brain—schizophrenia	0.000463	0.00443	CbGeAlD
Quinidine barbiturate—Phenobarbital—ABCB1—schizophrenia	0.000269	0.0224	CrCbGaD
Quinidine barbiturate—GABRA2—Neuronal System—MAOA—schizophrenia	0.000108	0.000332	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCKAR—schizophrenia	0.000107	0.000331	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL1B—schizophrenia	0.000107	0.00033	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—DRD3—schizophrenia	0.000106	0.000327	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—GRIN2B—schizophrenia	0.000106	0.000327	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL10—schizophrenia	0.000105	0.000325	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—schizophrenia	0.000105	0.000325	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC18A2—schizophrenia	0.000105	0.000322	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—schizophrenia	0.000104	0.00032	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL1B—schizophrenia	0.000104	0.00032	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—GABRB2—schizophrenia	0.000103	0.000318	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—DRD4—schizophrenia	0.000103	0.000318	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—YWHAZ—schizophrenia	0.000103	0.000317	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—MEF2C—schizophrenia	0.000103	0.000316	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—schizophrenia	0.000102	0.000313	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2C—schizophrenia	0.000102	0.000313	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CHRM1—schizophrenia	0.0001	0.000309	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—YWHAZ—schizophrenia	9.92e-05	0.000306	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—schizophrenia	9.85e-05	0.000304	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CNR1—schizophrenia	9.84e-05	0.000303	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	9.72e-05	0.000299	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC6A1—schizophrenia	9.63e-05	0.000297	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DGKI—schizophrenia	9.61e-05	0.000296	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—DRD2—schizophrenia	9.6e-05	0.000296	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—EP300—schizophrenia	9.59e-05	0.000295	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—schizophrenia	9.57e-05	0.000295	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	9.38e-05	0.000289	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	9.38e-05	0.000289	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HTR2A—schizophrenia	9.33e-05	0.000288	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GRM5—schizophrenia	9.32e-05	0.000287	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—EP300—schizophrenia	9.29e-05	0.000286	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—COMT—schizophrenia	9.25e-05	0.000285	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—MAOA—schizophrenia	9.19e-05	0.000283	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—CNR1—schizophrenia	9.13e-05	0.000281	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	9.03e-05	0.000278	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC18A2—schizophrenia	8.92e-05	0.000275	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—schizophrenia	8.91e-05	0.000275	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—schizophrenia	8.91e-05	0.000275	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	8.89e-05	0.000274	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DGKI—schizophrenia	8.73e-05	0.000269	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	8.72e-05	0.000269	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	8.72e-05	0.000269	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ATP2A2—schizophrenia	8.58e-05	0.000264	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCK—schizophrenia	8.52e-05	0.000263	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	8.44e-05	0.00026	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC6A1—schizophrenia	8.21e-05	0.000253	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	8.2e-05	0.000253	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCKAR—schizophrenia	8.17e-05	0.000252	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—GSK3B—schizophrenia	8.12e-05	0.00025	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PPP1R1B—schizophrenia	7.98e-05	0.000246	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—ADORA2A—schizophrenia	7.92e-05	0.000244	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MEF2C—schizophrenia	7.91e-05	0.000244	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	7.83e-05	0.000241	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—TNF—schizophrenia	7.78e-05	0.00024	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—CYP1A2—schizophrenia	7.68e-05	0.000237	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—TAAR6—schizophrenia	7.68e-05	0.000237	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GRM2—schizophrenia	7.68e-05	0.000237	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	7.63e-05	0.000235	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	7.63e-05	0.000235	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—CYP1A2—schizophrenia	7.58e-05	0.000234	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—TNF—schizophrenia	7.54e-05	0.000232	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—FZD3—schizophrenia	7.42e-05	0.000229	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—NPY—schizophrenia	7.4e-05	0.000228	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ATP2A2—schizophrenia	7.32e-05	0.000225	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR1B—schizophrenia	7.14e-05	0.00022	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—OXT—schizophrenia	7.14e-05	0.00022	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—NGEF—schizophrenia	7.11e-05	0.000219	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL1B—schizophrenia	7.07e-05	0.000218	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PPP3CC—schizophrenia	6.98e-05	0.000215	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—TAAR6—schizophrenia	6.98e-05	0.000215	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GRM2—schizophrenia	6.98e-05	0.000215	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—NTS—schizophrenia	6.95e-05	0.000214	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR1A—schizophrenia	6.87e-05	0.000212	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC6A3—schizophrenia	6.86e-05	0.000211	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—AKT1—schizophrenia	6.78e-05	0.000209	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—NPS—schizophrenia	6.77e-05	0.000209	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR2C—schizophrenia	6.64e-05	0.000205	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD1—schizophrenia	6.64e-05	0.000205	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—RGS4—schizophrenia	6.53e-05	0.000201	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GRM3—schizophrenia	6.53e-05	0.000201	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—NGEF—schizophrenia	6.45e-05	0.000199	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—COMT—schizophrenia	6.44e-05	0.000198	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD3—schizophrenia	6.43e-05	0.000198	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR6—schizophrenia	6.41e-05	0.000198	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTP1—schizophrenia	6.41e-05	0.000197	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—MAOA—schizophrenia	6.39e-05	0.000197	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—COMT—schizophrenia	6.35e-05	0.000196	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GSTP1—schizophrenia	6.32e-05	0.000195	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—EP300—schizophrenia	6.32e-05	0.000195	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—NTS—schizophrenia	6.31e-05	0.000194	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	6.24e-05	0.000192	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD4—schizophrenia	6.24e-05	0.000192	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CNR1—schizophrenia	5.96e-05	0.000184	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—RGS4—schizophrenia	5.93e-05	0.000183	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GRM3—schizophrenia	5.93e-05	0.000183	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTM1—schizophrenia	5.89e-05	0.000181	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC6A3—schizophrenia	5.85e-05	0.00018	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR6—schizophrenia	5.82e-05	0.000179	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD2—schizophrenia	5.81e-05	0.000179	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR7—schizophrenia	5.81e-05	0.000179	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GSTM1—schizophrenia	5.81e-05	0.000179	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—GSK3B—schizophrenia	5.79e-05	0.000179	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CHRM1—schizophrenia	5.66e-05	0.000174	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL1B—schizophrenia	5.53e-05	0.00017	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IL3RA—schizophrenia	5.52e-05	0.00017	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PRODH—schizophrenia	5.51e-05	0.00017	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ABCB1—schizophrenia	5.5e-05	0.000169	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	5.35e-05	0.000165	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GRM5—schizophrenia	5.26e-05	0.000162	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DGKI—schizophrenia	5.15e-05	0.000159	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CHRM1—schizophrenia	5.14e-05	0.000158	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TNF—schizophrenia	5.13e-05	0.000158	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL3RA—schizophrenia	5.01e-05	0.000154	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—EP300—schizophrenia	4.95e-05	0.000152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCK—schizophrenia	4.82e-05	0.000148	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GRM5—schizophrenia	4.78e-05	0.000147	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PPP1R1B—schizophrenia	4.71e-05	0.000145	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PDE4B—schizophrenia	4.69e-05	0.000145	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ABCB1—schizophrenia	4.69e-05	0.000144	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCKAR—schizophrenia	4.62e-05	0.000142	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MPC2—schizophrenia	4.49e-05	0.000138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADORA2A—schizophrenia	4.48e-05	0.000138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FZD3—schizophrenia	4.38e-05	0.000135	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCK—schizophrenia	4.37e-05	0.000135	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—APOA1—schizophrenia	4.34e-05	0.000134	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PDE4B—schizophrenia	4.26e-05	0.000131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCKAR—schizophrenia	4.19e-05	0.000129	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—NPY—schizophrenia	4.18e-05	0.000129	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PLCH2—schizophrenia	4.18e-05	0.000129	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PPP3CC—schizophrenia	4.12e-05	0.000127	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FES—schizophrenia	4.12e-05	0.000127	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TAAR6—schizophrenia	4.12e-05	0.000127	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRM2—schizophrenia	4.12e-05	0.000127	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR2A—schizophrenia	4.07e-05	0.000125	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADORA2A—schizophrenia	4.06e-05	0.000125	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR1B—schizophrenia	4.04e-05	0.000124	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—OXT—schizophrenia	4.04e-05	0.000124	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TNF—schizophrenia	4.01e-05	0.000124	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NDST3—schizophrenia	3.93e-05	0.000121	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR1A—schizophrenia	3.88e-05	0.00012	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—NPS—schizophrenia	3.83e-05	0.000118	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EP300—schizophrenia	3.81e-05	0.000117	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NGEF—schizophrenia	3.81e-05	0.000117	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—NPY—schizophrenia	3.8e-05	0.000117	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR2C—schizophrenia	3.75e-05	0.000116	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD1—schizophrenia	3.75e-05	0.000116	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NTS—schizophrenia	3.73e-05	0.000115	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC27A5—schizophrenia	3.72e-05	0.000115	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ACSL6—schizophrenia	3.72e-05	0.000115	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—APOA1—schizophrenia	3.7e-05	0.000114	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR1B—schizophrenia	3.66e-05	0.000113	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—OXT—schizophrenia	3.66e-05	0.000113	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD3—schizophrenia	3.63e-05	0.000112	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—DAO—schizophrenia	3.55e-05	0.000109	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR1A—schizophrenia	3.53e-05	0.000109	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD4—schizophrenia	3.53e-05	0.000109	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RGS4—schizophrenia	3.5e-05	0.000108	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RTN4—schizophrenia	3.5e-05	0.000108	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRM3—schizophrenia	3.5e-05	0.000108	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—NPS—schizophrenia	3.47e-05	0.000107	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR6—schizophrenia	3.44e-05	0.000106	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR2C—schizophrenia	3.41e-05	0.000105	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD1—schizophrenia	3.41e-05	0.000105	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PNP—schizophrenia	3.4e-05	0.000105	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CNR1—schizophrenia	3.37e-05	0.000104	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAG—schizophrenia	3.32e-05	0.000102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD3—schizophrenia	3.3e-05	0.000102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR7—schizophrenia	3.29e-05	0.000101	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD2—schizophrenia	3.29e-05	0.000101	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD4—schizophrenia	3.2e-05	9.87e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NDUFV2—schizophrenia	3.16e-05	9.75e-05	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TNF—schizophrenia	3.09e-05	9.54e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CNR1—schizophrenia	3.06e-05	9.42e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CHRM1—schizophrenia	3.04e-05	9.36e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD2—schizophrenia	2.98e-05	9.19e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR7—schizophrenia	2.98e-05	9.19e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIP4K2A—schizophrenia	2.98e-05	9.17e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL3RA—schizophrenia	2.96e-05	9.12e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TLE1—schizophrenia	2.89e-05	8.9e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NRG3—schizophrenia	2.89e-05	8.9e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GFAP—schizophrenia	2.86e-05	8.8e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRM5—schizophrenia	2.82e-05	8.7e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TLE3—schizophrenia	2.74e-05	8.43e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP26B1—schizophrenia	2.69e-05	8.29e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCK—schizophrenia	2.58e-05	7.96e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PDE4B—schizophrenia	2.52e-05	7.76e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCKAR—schizophrenia	2.48e-05	7.63e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADORA2A—schizophrenia	2.4e-05	7.4e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TPH1—schizophrenia	2.4e-05	7.39e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GCLM—schizophrenia	2.4e-05	7.39e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PLA2G4A—schizophrenia	2.36e-05	7.28e-05	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—AKT1—schizophrenia	2.3e-05	7.1e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGA—schizophrenia	2.3e-05	7.09e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR2A—schizophrenia	2.3e-05	7.09e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PRKD1—schizophrenia	2.25e-05	6.95e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NPY—schizophrenia	2.24e-05	6.91e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ATP2A2—schizophrenia	2.24e-05	6.91e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOTCH4—schizophrenia	2.24e-05	6.91e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—OXT—schizophrenia	2.16e-05	6.67e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR1B—schizophrenia	2.16e-05	6.67e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR2A—schizophrenia	2.09e-05	6.44e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR1A—schizophrenia	2.08e-05	6.42e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NPS—schizophrenia	2.05e-05	6.32e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR2C—schizophrenia	2.01e-05	6.2e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD1—schizophrenia	2.01e-05	6.2e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NTRK2—schizophrenia	1.96e-05	6.03e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD3—schizophrenia	1.95e-05	6e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD4—schizophrenia	1.89e-05	5.83e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GAPDH—schizophrenia	1.88e-05	5.8e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CLOCK—schizophrenia	1.87e-05	5.75e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TPH2—schizophrenia	1.82e-05	5.6e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CACNB2—schizophrenia	1.82e-05	5.6e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CNR1—schizophrenia	1.81e-05	5.57e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—DPYD—schizophrenia	1.79e-05	5.51e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD2—schizophrenia	1.76e-05	5.43e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR7—schizophrenia	1.76e-05	5.43e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRL—schizophrenia	1.66e-05	5.13e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CACNA1C—schizophrenia	1.66e-05	5.12e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3C2A—schizophrenia	1.62e-05	4.99e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—S100B—schizophrenia	1.55e-05	4.78e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ERBB4—schizophrenia	1.48e-05	4.57e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SNAP25—schizophrenia	1.45e-05	4.48e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PLA2G4A—schizophrenia	1.39e-05	4.3e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NRG1—schizophrenia	1.37e-05	4.22e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MEF2C—schizophrenia	1.36e-05	4.18e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP1A2—schizophrenia	1.31e-05	4.05e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—YWHAZ—schizophrenia	1.31e-05	4.04e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TH—schizophrenia	1.3e-05	3.99e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ERBB3—schizophrenia	1.28e-05	3.95e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR2A—schizophrenia	1.23e-05	3.8e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOE—schizophrenia	1.15e-05	3.54e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOA1—schizophrenia	1.13e-05	3.5e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—COMT—schizophrenia	1.1e-05	3.39e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTP1—schizophrenia	1.1e-05	3.38e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ESR1—schizophrenia	1.1e-05	3.38e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MAOA—schizophrenia	1.09e-05	3.37e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCB1—schizophrenia	1.04e-05	3.2e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PLA2G4A—schizophrenia	1.01e-05	3.1e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTM1—schizophrenia	1.01e-05	3.1e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GSK3B—schizophrenia	9.94e-06	3.06e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MTHFR—schizophrenia	8.9e-06	2.74e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOE—schizophrenia	8.29e-06	2.55e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOA1—schizophrenia	8.19e-06	2.52e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKT1—schizophrenia	7.37e-06	2.27e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKT1—schizophrenia	6.69e-06	2.06e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EP300—schizophrenia	6.54e-06	2.02e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—EP300—schizophrenia	4.72e-06	1.46e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TP53—schizophrenia	4.68e-06	1.44e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKT1—schizophrenia	3.95e-06	1.22e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AKT1—schizophrenia	2.85e-06	8.79e-06	CbGpPWpGaD
